Updated daily

The medicine that
 transforms
lives

Medical news, research and health. Analysis of clinical advances, new treatments and medical technology. No noise, just what matters.

Specialties

Rheumatologist examining the hands of an arthritis patient
Featured
Specialties schedule 7 min read

Rheumatoid arthritis in 2026: biologics, JAK inhibitors, and cardiovascular safety

Brain MRI showing multiple sclerosis lesions
Specialties March 9, 2026

Multiple sclerosis in 2026: the "hit hard, hit early" strategy is now the standard

Ocrelizumab, ofatumumab, and ublituximab lead MS treatment in 2026. Evidence confirms that early high-efficacy treatment preserves neurological function.

Oncologist reviewing chest X-ray with lung tumor image
Specialties March 8, 2026

Lung cancer: immunotherapy in 2026 and 5-year survival in stage IV

20% of stage IV lung cancer patients survive beyond 5 years with pembrolizumab. 2026 algorithm, perioperative immunotherapy, and toxicity reviewed.

Dermatologist examining a patient's skin with inflammatory skin disease
Specialties March 7, 2026

Psoriasis in 2026: from anti-IL-17 biologics to the new oral TYK2 inhibitor

Bimekizumab, risankizumab, and deucravacitinib lead the new era of psoriasis treatment. PASI 100 rates of 60% and the first selective oral TYK2 inhibitor.

Cardiologist performing catheter cardiac ablation in electrophysiology lab
Specialties March 6, 2026

Atrial fibrillation ablation in 2026: cryoballoon, RF, and the rise of PFA

Pulsed field ablation (PFA) is revolutionizing AF treatment. Comparison with cryoballoon and RF, expanded indications, and current evidence.